InnoCare Announces Approval of Clinical Trial of SHP2 Inhibitor ICP-189 in Combination with EGFR Inhibitor Furmonertinib
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases,...

Karnataka High Court Quashes BJP Slogan FIR, Ads Case, Sets 24-Hour Custody Rule
Tamil Nadu Government Allows Six Daily Film Shows Starting at 6 AM
Ranji Trophy: How Nagwaswalla, Gaja, and Patel Put Gujarat in Control Against Kerala
Fielding Lapses in Kanpur Show Why Uttar Pradesh Cannot Rely Solely on Batting Power
Ashok Leyland share price jumps 11.65% on 23% rise in October CV sales 




























